ZEISS Retina Workflow Expands with New Imaging, Visualization, and Surgical Tools
Event summary
- ZEISS introduced the ALTA DUO 300, a multimodal imaging device combining OCT and fundus imaging, at EURETINA 2026.
- The HMDmd CR3 head-mounted 3D display integrates with the ARTEVO 850 surgical microscope for enhanced visualization.
- DORC ILM-BLUE and MEMBRANEBLUE-DUAL dyes reached the 3 million milestone in vitreoretinal surgeries.
- ZEISS completed the full integration of DORC under its single brand, streamlining customer relationships.
The big picture
ZEISS’s latest innovations reflect a broader trend in ophthalmology toward integrated digital workflows that streamline diagnosis and surgery. The full integration of DORC under the ZEISS brand simplifies customer interactions while expanding its portfolio in vitreoretinal surgery. With retinal care growing more complex, ZEISS aims to position itself as a one-stop solution provider, leveraging data-driven decision-making to improve patient outcomes.
What we're watching
- Integration Success
- Whether ZEISS can fully realize operational efficiencies from the DORC acquisition.
- Market Adoption
- The pace at which the ALTA DUO 300 and HMDmd CR3 gain traction in clinical settings.
- Competitive Positioning
- How ZEISS’s expanded Retina Workflow affects its standing against rivals in retinal care.